You are here: Industry Insights > china

News List

China National Medical Products Administration Approves Sinovant's Clinical Trial Application for Derazantinib prnewswire
April 29, 2019
Sinovant Sciences today announced that its Clinical Trial Application (CTA) for derazantinib has been accepted by the Center for Drug Evaluation at the China National Medical Products Administration (NMPA)
Eli Lilly Sells Two Legacy Drugs and Manufacturing Facility in China for $375M biospace
April 24, 2019
Eli Lilly has inked a $375 million deal with China-based Eddingpharm for the rights to two legacy antibiotic medicines and manufacturing facility in Suzhou, China.
Hot Battle! Which to be the Next “Hanlikang”? PharmaSources/Caicai
April 23, 2019
A drug has been approved for marketing on an ordinary day! It seems nothing, but in fact, it means something!
China’s NMPA approves Novartis’ Cosentyx and Merck’s Keytruda pharmaceutical-technology
April 23, 2019
Novartis has announced that the Chinese National Medical Product Administration (NMPA) has approved its plaque psoriasis drug Cosentyx (secukinumab).
China's GenScript starts on plasmid, virus making facility fiercepharma
April 22, 2019
Chinese CDMO GenScript Biotech already has a deal to produce a CAR-T drug being developed by its Legend Biotech unit and Janssen.
China SXT Pharma announces pricing of a $15 Million PIPE financing biospectrumasia
April 21, 2019
Series A Note in the principal amount of $10 million, and a Series B Note in the principal amount of $5 million
China introduces new laws to ensure steady supply of drugs pharmafile
April 17, 2019
China’s National Health Commission (NHC) has said it will monitor the country’s drugs market more closely in order to ensure a sufficient supply of essential medicines.
Rexahn & BioSense Enter License Agreement contractpharma
April 17, 2019
To advance the development and commercialization of RX-3117 for pancreatic cancer and other cancers in Greater China...
Global Innovative Drugs Speeding up to Enter China with the Help from Policies PharmaSources/1℃
April 17, 2019
The National Medical Products Administration (NMPA) and National Health Commission of China organized relevant experts on Mar. 28, 2019 to...
Luqa Pharmaceuticals and Ferrer Internacional S.A. …… firstwordpharma
April 14, 2019
Shanghai, P.R. China and Barcelona, Spain, April 9th 2019 - Luqa Pharmaceuticals ("Luqa")……

Previous page 1 2 3 4 5 6 7 8 9 10 ... 38 39 Next page